Increasing Access to Medicines

Teva’s mission is to improve lives around the world, and we do so by providing high quality, safe and affordable medicines. Leveraging our company’s broad generics portfolio, which includes most of the medicines on the World Health Organization’s list of Essential Medicines, we imagine new ways to bring more medicines to vulnerable populations. One way we expand our reach is through our access to medicines programs.

We have committed to launch eight of these programs by 2025.

Increasing Access to Medicines

Leveraging Teva’s broad generics portfolio, which includes most of the medicines on the World Health Organization’s list of Essential Medicines, we imagine new ways to bring more medicines to vulnerable populations. One way we expand our reach is through our access to medicines programs.


Here's a look at our current access to medicines programs:

Botswana, Malawi, Rwanda, Tanzania, Uganda: We have partnered with Global HOPE (Hematology-Oncology Pediatric Excellence) to address pediatric cancer and blood disorders in Malawi since 2020 and have expanded the program to Uganda, Botswana, Tanzania and Rwanda. This program is unique, with a focus on capacity building and training of local pediatric oncology staff, and is done in partnership with Direct Relief and Texas Children's Hospital.

France: Through a social business program, we provide low-cost medicines to Pharmacie Humanitaire International (PHI), an organization that facilitates delivery to charitable care centers where patients can access free medicines. These medicines address needs including cardiovascular disease, infectious diseases, pain, mental health and more.

Ghana: In partnership with Direct Relief and Breast Cancer International, we provide high-quality medicines for cancer treatments, specifically for women with breast cancer, helping to combat counterfeit medicines.

Israel: We are helping the statusless population, which consists largely of asylum seekers from Eritrea and Sudan, along with refugees from Ukraine and other areas, who have no access to basic healthcare and are not included in the national health insurance scheme. Designated clinics who know their needs best remain the only health care option for this population. With our partners at Terem Clinic, Naavat David and Ruth Clinic, the program takes an innovative approach to give patients access to needed medicines at no cost.

United States: In partnership with Direct Relief and the National Association of Free & Charitable Clinics, we are advancing access to mental health care for uninsured and underserved patients, including racial and ethnic minorities and the LGBTQIA+ community. Teva is making available, on a charitable basis, a portfolio of commonly used generic medicines that treat depression and anxiety and providing $2 million in grant funding over two years, as of 2022, to support innovative programs from qualified free and charitable clinics in California, Florida and New Jersey that advance health equity through mental and behavioral health services.

NPS-ALL-NP-00866-FEBURARY-2023


Find out more:

Share this article:

You might also be interested

Why Diversity in Clinical Trials is So Important

Why Diversity in Clinical Trials is So Important

Meet Our
People

Meet our People: Merle Goddard

Meet our People: Merle Goddard

Teva receives the Equality 100 award on Human Rights Campaign Foundation's Annual Scorecard Assessin...

Teva receives the Equality 100 award on Human Rights Campaign Foundation's Annual Scorecard Assessing LGBTQIA+ Workplace Equality

Behind the
Numbers

“Mental health care is not a one stop deal": How Teva is Combining Medicine and Ongoing Support

“Mental health care is not a one stop deal": How Teva is Combining Medicine and Ongoing Support

3 Trends

3 Trends I’m Watching in Patient Safety

3 Trends I’m Watching in Patient Safety